Background—Currently available catheter techniques for closure of a patent foramen ovale
(PFO) rely on the placement of an implantable closure device. The objective of the Paradigm …

Aims: Currently available devices for transcatheter closure of patent foramen ovale (PFO)
which rely on a permanent implant have limitations, including late complications. The study …

ABSTRACT Background: Patent Foramen Ovale (PFO) occurs in approximately 25% of the
population and has been implicated in the etiology of cryptogenic stroke. Although the exact …

Objectives: This study sought to examine the frequency of indications for and the immediate
and long-term clinical outcomes of transcatheter closure of patent foramen ovale (PFO) …

Aims: To summarise our experiences of device closure of residual shunt after transcatheter
closure of patent foramen ovale (PFO). Methods and results: Since October 1997 …

Transcatheter closure of a patent foramen ovale (PFO) reduces the risk of recurrent
cryptogenic stroke compared with medical therapy. PFO closure is a prophylactic procedure …

Patent foramen ovale (PFO) is a common abnormality affecting between 20% and 34% of
the adult population. For most people, it is a benign finding; however, in some people, the …

Background: Permanent implants for closure of a patent foramen ovale (PFO) have a
number of possible disadvantages including erosions, thrombus formation, and allergic …

Closure of interatrial septal defects with percutaneous devices is increasingly common.
However, the indications for closure and techniques for device implantation are diverse. We …

Aims Percutaneous patent foramen ovale (PFO) closure for secondary stroke prevention is
discussed controversially. Long-term data comparing different closure devices are limited …